BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4768397)

  • 1. HL-A antigens and diseases. I. Multiple sclerosis.
    Jersild C; Svejgaard A; Fog T; Ammitzboll T
    Tissue Antigens; 1973; 3(4):243-50. PubMed ID: 4768397
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of association between HL-A antigens and measles antibody in multiple sclerosis.
    Bertrams J; von Fisenne E; Hoher PG; Kuwert E
    Lancet; 1973 Aug; 2(7826):441. PubMed ID: 4124913
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte-mediated cytotoxicity to viruses in patients with multiple sclerosis: presence of a blocking factor.
    Rola-Pleszczynski M; Abernathy M; Vincent MM; Hensen SA; Bellanti JA
    Clin Immunol Immunopathol; 1976 Mar; 5(2):165-72. PubMed ID: 1084246
    [No Abstract]   [Full Text] [Related]  

  • 4. Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis.
    Arnason BG; Fuller TC; Lehrich JR; Wray SH
    J Neurol Sci; 1974 Aug; 22(4):419-28. PubMed ID: 4847303
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between HL-A antigens and measles antibody in multiple sclerosis.
    Jersild C; Ammitzboll T; Clausen J; Fog T
    Lancet; 1973 Jan; 1(7795):151-2. PubMed ID: 4118494
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte-mediated cytotoxicity to measles virus in patients with multiple sclerosis.
    Huddlestone JR; Oldstone MB
    Clin Immunol Immunopathol; 1979 Aug; 13(4):444-51. PubMed ID: 487666
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of 39 cases of multiple sclerosis (MS) including 2 familial cases. Leukocyte migration inhibition test in the presence of measles antigen with and without levamisole. HL-A typing (SD)].
    Hainaut J; Ribot C; Lefebvre P; Goasguen J; Piette JP
    Ann Med Interne (Paris); 1977 Oct; 128(10):767-72. PubMed ID: 931233
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Lymphocyte-mediated cytotoxicity to viruses in patients with multiple sclerosis: presence of a blocking factor.
    Rola-Pleszczynski M; Bellanti J; Abernathy M; Vincent MM; Hensen SA
    Neurology; 1975 May; 25(5):491. PubMed ID: 1169714
    [No Abstract]   [Full Text] [Related]  

  • 9. HL-A antigens and multiple sclerosis.
    Bertrams J; Kuwert E; Liedtke U
    Tissue Antigens; 1972; 2(5):405-8. PubMed ID: 4655776
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement dependen cytotoxic antibody activity against measles virus in multiple sclerosis.
    Kratzsch V; Kiessling WR
    J Neurol; 1977 Aug; 216(1):39-46. PubMed ID: 72792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: S.S.P.E. and multiple sclerosis.
    Furlan AJ; Rothner AD
    Lancet; 1974 Jun; 1(7866):1113. PubMed ID: 4135276
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple sclerosis: cellular and humoral immune responses to several viruses.
    Fuccillo DA; Madden DL; Castellano GA; Uhlig L; Traub RG; Mattson J; Krezlewicz A; Sever JL
    Neurology; 1978 Jun; 28(6):613-5. PubMed ID: 206860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pathogenesis of multiple cerebrospinal sclerosis. Present state of knowledge and concepts (author's transl)].
    Jedlicka P
    Cas Lek Cesk; 1978 Apr; 117(15):449-53. PubMed ID: 350405
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis: etiologic and diagnostic significance of measles virus antibodies in the cerebrospinal fluid and serum.
    Cendrowski W; Niedzielska K
    Schweiz Arch Neurol Neurochir Psychiatr; 1974; 114(2):215-28. PubMed ID: 4421491
    [No Abstract]   [Full Text] [Related]  

  • 15. Virus antibodies and multiple sclerosis.
    Sever JL; Kurtzke JF; Alter M; Schumacher GA; Gilkeson MR; Ellenberg JH; Brody JA
    Arch Neurol; 1971 Jun; 24(6):489-94. PubMed ID: 4326199
    [No Abstract]   [Full Text] [Related]  

  • 16. Histocompatibility types and measles antibodies in multiple sclerosis.
    Fewster ME; Myers LW; Ellison GW; Walford RL
    J Neurol Sci; 1977 Nov; 34(2):287-96. PubMed ID: 925715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetical aspects of multiple sclerosis with special regard to histocompatibility determinants.
    Kuwert EK
    Acta Neurol Scand Suppl; 1977; 63():23-42. PubMed ID: 66850
    [No Abstract]   [Full Text] [Related]  

  • 18. Measles antibody in serum of multiple sclerosis patients, their children, siblings and parents.
    Ammitzboll T; Clausen J; Fog T
    Acta Neurol Scand Suppl; 1972; 51():365. PubMed ID: 4514352
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relation between canine morbilli virus infection and the measles antibody titer in patients with multiple sclerosis].
    Mititelu G; Cernescu C; Bourceanu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(3):185-90. PubMed ID: 2948261
    [No Abstract]   [Full Text] [Related]  

  • 20. [The determination of viral antibodies in patients with disseminated sclerosis].
    Chaplygina NM; Bogomolova NN; Koptiaeva IB; Desiatskova RG; Zavalishin IA; Adarcheva LS; Timirbaeva SL; Ivanova-Smolenskaia IA; Iakovleva LS; Morozov VA
    Vopr Virusol; 1990; 35(3):240-1. PubMed ID: 2219859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.